Cyber Defense Magazine's 13th Annual Awards taking place during CyberDefenseCon 2025 in Orlando Florida ORLANDO, Fla., Oct. 28, 2025 /PRNewswire-PRWeb/ -- Cyber Defense Magazine, the industry's...

Pioneering data demonstrate that Acurx's U.S. and EU Phase 3-ready DNA pol IIIC inhibitor, ibezapolstat (IBZ), has unique selective antibacterial activity in the gut which spares beneficial bile...

RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics to cure common autoimmune diseases, today announced groundbreaking preclinical research that supports a...

CWSS-SCM and NCWSS will provide ample weed science research presentations and learning opportunities at their November and December meetings WESTMINSTER, Colo., Oct. 28, 2025 /PRNewswire/ -- Two...

HUMAIN, a global AI company under the Public Investment Fund (PIF) building end-to-end AI stack capabilities, today announced the launch of HUMAIN ONE, its proprietary agentic AI operating system,...

Anomaly detection use case will be demonstrated live with partner Q-KON at AfricaCom 2025 HERNDON, Va., Oct. 28, 2025 /PRNewswire/ -- ST Engineering iDirect, a global leader in satellite...

Reqorsa® Gene Therapy is a Potential Treatment for ALK-EML4 Positive Translocated Non-Small Cell Lung Cancer Combining REQORSA with Alectinib Further Increased Apoptosis and Improved Treatment...

Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase 2b study met primary endpoint. No symptomatic intracranial hemorrhage occurred. Data suggest that...

Meiyume, a pioneer in end-to-end beauty solutions, presents SEEDED — Rooted in Intelligence, Connected Through the Beauty Vein at Cosmopack Asia. As a global leader in packaging, turnkey product...

Global consumers are placing a higher value on sustainability, personalization, and aesthetics in their daily lives. This has led to a growing demand for eco-friendly and thoughtfully designed...